Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 70,000 shares at $187.18 ($13.2M) on 2015-12-08, disclosed to the SEC on 2015-12-08.
Scheduled sale ($13.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $185.30 | 20,318 | $3.8M | 28.6% |
| 2 | $187.18 | 10,478 | $2.0M | 14.9% |
| 3 | $187.88 | 100 | $19K | 0.1% |
| 4 | $189.69 | 15,238 | $2.9M | 21.9% |
| 5 | $190.16 | 23,866 | $4.5M | 34.4% |
| Total | $188.20 avg | 70,000 |
| $13.2M |
| 100% |
| Filing → |
| ALXN | SELL | 2017-02-08 | $2.2M | — | Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |